{"entity":{"edinet_code":"E02688","sec_code":"8086","name_ja":"ニプロ株式会社","name_en":"NIPRO CORPORATION","industry":"精密機器","industry_en":"Precision Instruments"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100YJLK","filer_name":"ニプロ株式会社","filer_name_en":"NIPRO CORPORATION","period_end":"2026-03-31","filed_date":"2026-06-25","sha256":"11237cd9b0560f3e7d3eb912e5b00d8d97874d917b168f83bf0cd4a30228b0c5","status":"clean"},"basis":{"measurement":"carrying_amount","entity_scope":"parent_only","share_scope":"both","trust_included":"unknown","as_of":"2026-03-31","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"The reporting company itself (提出会社) — the holding company, excluding the group holders it names separately.","share_scope":"Listed and unlisted shares together.","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"reporting","held_name_raw":"日本電気硝子㈱","held_name_en":"Nippon Electric Glass Co., Ltd.","held_sec_code":"5214","match_status":"matched","shares":1254920,"book_value_yen":7420000000,"prior_shares":1254920,"prior_book_value_yen":4375000000,"purpose_ja":"(保有目的)原材料の取引先であり、良好な取引関係を維持・強化させるため保有しています。","reciprocal":"有","pct_outstanding":1.6681478016278597,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":2.2164338714109904,"pct_of_holder_assets":0.6115603029778536,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"有機合成薬品工業㈱","held_name_en":"YUKI GOSEI KOGYO CO., LTD.","held_sec_code":"4531","match_status":"matched","shares":3296300,"book_value_yen":1285000000,"prior_shares":3296300,"prior_book_value_yen":873000000,"purpose_ja":"(保有目的)原材料の取引先であり、良好な取引関係を維持・強化させるため保有しています。","reciprocal":"有","pct_outstanding":15.250975075993468,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3838433321783184,"pct_of_holder_assets":0.10591037592001912,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"木村化工機㈱","held_name_en":"KIMURA CHEMICAL PLANTS CO., LTD.","held_sec_code":"6378","match_status":"matched","shares":400000,"book_value_yen":607000000,"prior_shares":400000,"prior_book_value_yen":291000000,"purpose_ja":"(保有目的)機械設備の取引先であり、良好な取引関係を維持・強化させるため保有しています。  ","reciprocal":"有","pct_outstanding":1.9417569988203827,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.18131743395505,"pct_of_holder_assets":0.05002925928673277,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"象印マホービン㈱","held_name_en":"Zojirushi Corporation","held_sec_code":"7965","match_status":"matched","shares":363000,"book_value_yen":604000000,"prior_shares":363000,"prior_book_value_yen":543000000,"purpose_ja":"(保有目的)原材料の取引先であり、良好な取引関係を維持・強化させるため保有しています。 ","reciprocal":"有","pct_outstanding":0.5742725880551302,"pct_unavailable":null,"pct_basis_period_end":"2025-11-20","pct_share_classes":1,"pct_of_holder_equity":0.1804213016620267,"pct_of_holder_assets":0.04978199770870938,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"澁谷工業㈱","held_name_en":"SHIBUYA CORPORATION","held_sec_code":"6340","match_status":"matched","shares":150000,"book_value_yen":503000000,"prior_shares":150000,"prior_book_value_yen":480000000,"purpose_ja":"(保有目的)製商品の取引先であり、良好な取引関係を維持・強化させるため保有しています。  ","reciprocal":"有","pct_outstanding":0.5421763108928607,"pct_unavailable":null,"pct_basis_period_end":"2026-06-30","pct_share_classes":1,"pct_of_holder_equity":0.1502515144635752,"pct_of_holder_assets":0.04145752458192188,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"グロースエクスパートナーズ㈱","held_name_en":"Growth xPartners,inc.","held_sec_code":"244A","match_status":"matched","shares":130000,"book_value_yen":154000000,"prior_shares":130000,"prior_book_value_yen":209000000,"purpose_ja":"(保有目的)ITを用いた新規事業創出及び社内業務改善に強みをもつ同社との資本業務提携契約の締結により企業価値向上を図るため保有しています。 ","reciprocal":"有","pct_outstanding":3.9031537482285685,"pct_unavailable":null,"pct_basis_period_end":"2025-08-31","pct_share_classes":1,"pct_of_holder_equity":0.04600145770852999,"pct_of_holder_assets":0.012692761005200736,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱メディパルホールディングス","held_name_en":"MEDIPAL HOLDINGS CORPORATION","held_sec_code":"7459","match_status":"matched","shares":44500,"book_value_yen":130000000,"prior_shares":44500,"prior_book_value_yen":103000000,"purpose_ja":"(保有目的)医療用医薬品の取引先であり、取引関係を維持・強化させるため保有しています。","reciprocal":"有","pct_outstanding":0.021739274655275927,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.038832399364343496,"pct_of_holder_assets":0.010714668381013608,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"クオールホールディングス㈱","held_name_en":"Qol Holdings Co.,Ltd.","held_sec_code":"3034","match_status":"matched","shares":43600,"book_value_yen":81000000,"prior_shares":43600,"prior_book_value_yen":78000000,"purpose_ja":"(保有目的)医療用医薬品の取引先であり、取引関係を維持・強化させるため保有しています。 ","reciprocal":"有","pct_outstanding":0.11602661533464698,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.024195571911629406,"pct_of_holder_assets":0.006676062606631556,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱あいちフィナンシャルグループ","held_name_en":"Aichi Financial Group, Inc.","held_sec_code":"7389","match_status":"matched","shares":21794,"book_value_yen":29000000,"prior_shares":21794,"prior_book_value_yen":62000000,"purpose_ja":"(保有目的)主要取引金融機関である発行会社傘下のあいち銀行と財務面で取引があり、資金調達等の円滑化のため、保有しています。","reciprocal":"無(注)３","pct_outstanding":0.04470997812280088,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.00866261216589201,"pct_of_holder_assets":0.0023901952542261123,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":["3"],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"わかもと製薬㈱","held_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","held_sec_code":"4512","match_status":"matched","shares":34300,"book_value_yen":12000000,"prior_shares":34300,"prior_book_value_yen":10000000,"purpose_ja":"(保有目的) 医療用医薬品の取引先であり、取引関係を維持・強化させるため保有しています。","reciprocal":"有","pct_outstanding":0.09883038703045662,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0035845291720932454,"pct_of_holder_assets":0.0009890463120935638,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"第一生命ホールディングス㈱","held_name_en":"Daiichi Life Group, Inc.","held_sec_code":"8750","match_status":"matched","shares":8400,"book_value_yen":11000000,"prior_shares":8400,"prior_book_value_yen":9000000,"purpose_ja":"(保有目的)保険取引を通じて、良好な取引関係を維持・強化させるため保有しています。","reciprocal":"無(注)４","pct_outstanding":0.000232106327796026,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0032858184077521418,"pct_of_holder_assets":0.0009066257860857668,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":["4"],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱みずほフィナンシャルグループ","held_name_en":"Mizuho Financial Group, Inc.","held_sec_code":"8411","match_status":"matched","shares":1661,"book_value_yen":10000000,"prior_shares":1661,"prior_book_value_yen":6000000,"purpose_ja":"(保有目的)主要取引金融機関である発行会社傘下のみずほ銀行と財務面で取引があり、資金調達等の円滑化のため、保有しています。","reciprocal":"無(注)５","pct_outstanding":6.802375089929467e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.002987107643411038,"pct_of_holder_assets":0.0008242052600779698,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":["5"],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱モリタホールディングス","held_name_en":"MORITA HOLDINGS CORPORATION","held_sec_code":"6455","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":60000,"prior_book_value_yen":124000000,"purpose_ja":"(保有目的) 医療用医薬品の取引先であり、取引関係を維持・強化させるため保有していましたが、当事業年度において売却いたしました。 ","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"レンゴー㈱","held_name_en":"Rengo Co., Ltd.","held_sec_code":"3941","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":360000,"prior_book_value_yen":285000000,"purpose_ja":"(保有目的)原材料の取引先であり、良好な取引関係を維持・強化させるため保有しておりましたが、当事業年度において売却いたしました。 ","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":334772000000,"holder_total_assets_yen":1213290000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"日本電気硝子株式会社","holder_name_en":"Nippon Electric Glass Co., Ltd.","holder_sec_code":"5214","doc_id":"S100XU17","period_end":"2025-12-31","holder_table":"reporting","shares":10215000,"book_value_yen":15088000000,"prior_shares":13645000,"prior_book_value_yen":20427000000,"purpose_ja":"（保有目的）医薬容器向けの取引など、事業関係の強化に効果があると判断したため保有しているが、提出日（2026年３月26日）までに一部売却済。（定量的な保有効果）（注２）","reciprocal":"有","pct_outstanding":6.2402608938537485,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":3.040825827671757,"pct_of_holder_assets":2.151086449780657,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":496181000000,"holder_total_assets_yen":701413000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社あいちフィナンシャルグループ","holder_name_en":"Aichi Financial Group, Inc.","holder_sec_code":"7389","doc_id":"S100YE5H","period_end":"2026-03-31","holder_table":"largest","shares":550000,"book_value_yen":853000000,"prior_shares":550000,"prior_book_value_yen":747000000,"purpose_ja":"業界内の有力企業である同社との関係維持・向上を通じた、当行グループの企業価値向上のため。","reciprocal":"有","pct_outstanding":0.33599055228776914,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.19791137375551332,"pct_of_holder_assets":0.011899552155541794,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":431001000000,"holder_total_assets_yen":7168337000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"象印マホービン株式会社","holder_name_en":"Zojirushi Corporation","holder_sec_code":"7965","doc_id":"S100XL0K","period_end":"2025-11-20","holder_table":"reporting","shares":418000,"book_value_yen":615000000,"prior_shares":418000,"prior_book_value_yen":577000000,"purpose_ja":"連結子会社の仕入における関係性維持・強化を目的として取得し、保有を継続しています。同社株式について、保有コストに伴う便益やリスクが資本コストに見合っているかを検証し、取締役会で保有意義の確認を行っております。但し、定量効果の内容及び保有適否の検証結果については、取引関係や株式市場に与える影響を鑑みて開示を控えさせて頂きます。","reciprocal":"有","pct_outstanding":0.25535281973870455,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.6864682048019288,"pct_of_holder_assets":0.5197241659060947,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":89589000000,"holder_total_assets_yen":118332000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社愛知銀行","holder_name_en":"The Aichi Bank,Ltd.","holder_sec_code":"8527","doc_id":"S100OASF","period_end":"2022-03-31","holder_table":"reporting","shares":550000,"book_value_yen":563000000,"prior_shares":550000,"prior_book_value_yen":735000000,"purpose_ja":"業界内の有力企業である同社との関係維持・向上を通じた、当行グループの企業価値向上のため。","reciprocal":"有","pct_outstanding":0.3359870630075134,"pct_unavailable":null,"pct_basis_period_end":"2022-03-31","pct_share_classes":1,"pct_of_holder_equity":0.23506129129229433,"pct_of_holder_assets":0.013030148245130647,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":239512000000,"holder_total_assets_yen":4320749000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"澁谷工業株式会社","holder_name_en":"SHIBUYA CORPORATION","holder_sec_code":"6340","doc_id":"S100Z359","period_end":"2026-06-30","holder_table":"reporting","shares":340000,"book_value_yen":536000000,"prior_shares":340000,"prior_book_value_yen":434000000,"purpose_ja":"メカトロシステム事業における最大の取引先であり、医療機器の販売取引を行っております。また、パッケージングプラント事業においても製薬設備の販売取引を行っており、取引関係の維持・強化のため保有しております。","reciprocal":"有","pct_outstanding":0.2077032505051664,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.45007599230840284,"pct_of_holder_assets":0.30932594644506,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":119091000000,"holder_total_assets_yen":173280000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"レンゴー株式会社","holder_name_en":"Rengo Co., Ltd.","holder_sec_code":"3941","doc_id":"S100YI9N","period_end":"2026-03-31","holder_table":"reporting","shares":183510,"book_value_yen":284000000,"prior_shares":182514,"prior_book_value_yen":247000000,"purpose_ja":"当社の包装資材等の取引先であり、取引拡大に向け良好な信頼関係の維持・発展の目的により保有。株式数の増加は関係強化のため購入したことによるもの。","reciprocal":"無","pct_outstanding":0.1121047750005973,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.05373150141707375,"pct_of_holder_assets":0.021628438655198517,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":528554000000,"holder_total_assets_yen":1313086000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"グロースエクスパートナーズ株式会社","holder_name_en":"Growth xPartners,inc.","holder_sec_code":"244A","doc_id":"S100XJ6M","period_end":"2025-08-31","holder_table":"reporting","shares":118676,"book_value_yen":178548000,"prior_shares":108453,"prior_book_value_yen":140447000,"purpose_ja":"同社は、当社の主要取引先及び資本・業務提携先であり、同社グループとの取引関係の維持・強化を目的として保有しております。当事業年度の株式数増加は、取引先持株会での定期積立によるものであります。","reciprocal":"有","pct_outstanding":0.07249812011988446,"pct_unavailable":null,"pct_basis_period_end":"2025-03-31","pct_share_classes":1,"pct_of_holder_equity":5.286589352207157,"pct_of_holder_assets":3.7777127052745967,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":3377376000,"holder_total_assets_yen":4726352000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"木村化工機株式会社","holder_name_en":"KIMURA CHEMICAL PLANTS CO., LTD.","holder_sec_code":"6378","doc_id":"S100YF9Q","period_end":"2026-03-31","holder_table":"reporting","shares":109300,"book_value_yen":169000000,"prior_shares":109300,"prior_book_value_yen":148000000,"purpose_ja":"取引先との関係強化による収益拡大配当利回り等を含めた当社への便益   ―","reciprocal":"有","pct_outstanding":0.06677048611827849,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.8196323779038751,"pct_of_holder_assets":0.4998077662437524,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":20619000000,"holder_total_assets_yen":33813000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"有機合成薬品工業株式会社","holder_name_en":"YUKI GOSEI KOGYO CO., LTD.","holder_sec_code":"4531","doc_id":"S100YHPD","period_end":"2026-03-31","holder_table":"reporting","shares":100000,"book_value_yen":155000000,"prior_shares":100000,"prior_book_value_yen":135000000,"purpose_ja":"医薬品関係で取引があり、同社との業務提携及び資本提携のため、同社株式を保有しております。","reciprocal":"有","pct_outstanding":0.06108919132504893,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.1492548379921406,"pct_of_holder_assets":0.6024096385542169,"holder_equity_basis":"parent_only","holder_equity_yen":13487000000,"holder_total_assets_yen":25730000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社あおぞら銀行","holder_name_en":"Aozora Bank, Ltd.","holder_sec_code":"8304","doc_id":"S100YCRO","period_end":"2026-03-31","holder_table":"reporting","shares":91100,"book_value_yen":141000000,"prior_shares":91100,"prior_book_value_yen":123000000,"purpose_ja":"エンゲージメント投資として保有しております。","reciprocal":"無","pct_outstanding":0.05565225329711958,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.02868121339839833,"pct_of_holder_assets":0.001639215999027166,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":491611000000,"holder_total_assets_yen":8601673000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"クオールホールディングス株式会社","holder_name_en":"Qol Holdings Co.,Ltd.","holder_sec_code":"3034","doc_id":"S100YJYW","period_end":"2026-03-31","holder_table":"reporting","shares":80000,"book_value_yen":124000000,"prior_shares":80000,"prior_book_value_yen":108000000,"purpose_ja":"同社が製造するジェネリック医薬品を取扱っており、医薬品の流通における取引関係強化のために保有しております。","reciprocal":"有","pct_outstanding":0.04887135306003915,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.2072192513368984,"pct_of_holder_assets":0.07842343595841028,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":59840000000,"holder_total_assets_yen":158116000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社メディパルホールディングス","holder_name_en":"MEDIPAL HOLDINGS CORPORATION","holder_sec_code":"7459","doc_id":"S100YI1C","period_end":"2026-03-31","holder_table":"reporting","shares":79784,"book_value_yen":123000000,"prior_shares":79784,"prior_book_value_yen":108000000,"purpose_ja":"・当社グループの医療用医薬品等卸売事業の商品の仕入等における良好な取引関係の維持・強化のため、保有しております。・定量的な保有効果については、（注）１に記載しております。","reciprocal":"有","pct_outstanding":0.048739400406777045,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.015463936967484243,"pct_of_holder_assets":0.006399577107620075,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":795399000000,"holder_total_assets_yen":1922002000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社モリタホールディングス","holder_name_en":"MORITA HOLDINGS CORPORATION","holder_sec_code":"6455","doc_id":"S100YE56","period_end":"2026-03-31","holder_table":"reporting","shares":60000,"book_value_yen":93000000,"prior_shares":60000,"prior_book_value_yen":81000000,"purpose_ja":"主として防災事業の販路拡大を図るため、継続して保有しています。","reciprocal":"無","pct_outstanding":0.03665351479502936,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0907529567898825,"pct_of_holder_assets":0.06369601249263729,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":102476000000,"holder_total_assets_yen":146006000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"プラマテルズ株式会社","holder_name_en":"Pla Matels Corporation","holder_sec_code":"2714","doc_id":"S100G3DK","period_end":"2019-03-31","holder_table":"reporting","shares":31437,"book_value_yen":44000000,"prior_shares":29632,"prior_book_value_yen":45000000,"purpose_ja":null,"reciprocal":"無","pct_outstanding":0.019274987858633828,"pct_unavailable":null,"pct_basis_period_end":"2020-03-31","pct_share_classes":1,"pct_of_holder_equity":0.4255934901219751,"pct_of_holder_assets":0.15657812458408935,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":10338504000,"holder_total_assets_yen":28100988000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"東亜ディーケーケー株式会社","holder_name_en":"DKK-TOA CORPORATION","holder_sec_code":"6848","doc_id":"S100YFF9","period_end":"2026-03-31","holder_table":"reporting","shares":20000,"book_value_yen":31000000,"prior_shares":20000,"prior_book_value_yen":27000000,"purpose_ja":"（保有目的）　取引関係の強化を保有目的としています。定量的な保有効果の記載は困難ですが、商品の販売や仕入等の取引を行っており、経済的な合理性をもって継続保有しています。（定量的な保有効果）　（注）１","reciprocal":"無","pct_outstanding":0.012217838265009787,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.13504094790033108,"pct_of_holder_assets":0.10656583018219319,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":22956000000,"holder_total_assets_yen":29090000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"東北化学薬品株式会社","holder_name_en":"TOHOKU　CHEMICAL　CO.,　LTD.","holder_sec_code":"7446","doc_id":"S100XAMG","period_end":"2025-09-30","holder_table":"reporting","shares":12455,"book_value_yen":18750000,"prior_shares":11417,"prior_book_value_yen":16252000,"purpose_ja":"(保有目的)主としてインダストリーセグメントでの取引先関係の維持・強化(定量的な保有効果)　(注)1 (株式数が増加した理由)取引先持株会を通じた株式の取得 ","reciprocal":"無","pct_outstanding":0.007608658779534845,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.23380069781091473,"pct_of_holder_assets":0.10177591093918431,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":8019651000,"holder_total_assets_yen":18422827000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社電通グループ","holder_name_en":"DENTSU GROUP INC.","holder_sec_code":"4324","doc_id":"S100Y36E","period_end":"2025-12-31","holder_table":"reporting","shares":10000,"book_value_yen":14000000,"prior_shares":10000,"prior_book_value_yen":14000000,"purpose_ja":"（注）１．２．","reciprocal":"無","pct_outstanding":0.006108919132504893,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0037348372277903902,"pct_of_holder_assets":0.0004365740537179426,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":374849000000,"holder_total_assets_yen":3206787000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"わかもと製薬株式会社","holder_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4512","doc_id":"S100YDBU","period_end":"2026-03-31","holder_table":"reporting","shares":8000,"book_value_yen":12416000,"prior_shares":8000,"prior_book_value_yen":10868000,"purpose_ja":"同社傘下の企業が医薬事業、グローバル事業における仕入先及び顧客であり、取引関係の維持・強化のため保有しています。","reciprocal":"有","pct_outstanding":0.004887135306003915,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.10339273224704901,"pct_of_holder_assets":0.07525027717326843,"holder_equity_basis":"parent_only","holder_equity_yen":12008581000,"holder_total_assets_yen":16499607000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"アステナホールディングス株式会社","holder_name_en":"Astena Holdings Co., Ltd.","holder_sec_code":"8095","doc_id":"S100XN2T","period_end":"2025-11-30","holder_table":"reporting","shares":6293,"book_value_yen":9000000,"prior_shares":5779,"prior_book_value_yen":7000000,"purpose_ja":"定量的な保有効果の記載は困難ですが、主にファインケミカル事業における取引先であり、良好な関係の維持、強化を図るために保有しております。信頼関係の構築・維持強化の必要性や事業上の取引状況等に基づく保有意義、同社との取引関係等による経済合理性について経営陣が定期的に検証・審議を行い、保有の合理性があると判断しております。株式数増加の理由は、取引先持株会を通じた株式の取得であります。","reciprocal":"無","pct_outstanding":0.0038443428100853293,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.03285031207796474,"pct_of_holder_assets":0.011929852467491151,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":27397000000,"holder_total_assets_yen":75441000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社ＲＹＯＤＥＮ","holder_name_en":"RYODEN CORPORATION","holder_sec_code":"8084","doc_id":"S100YGNM","period_end":"2026-03-31","holder_table":"reporting","shares":6200,"book_value_yen":9000000,"prior_shares":5757,"prior_book_value_yen":7000000,"purpose_ja":"FAシステム事業における販売先であり、三菱電機製FA機器品を医療関連設備向けに納入しております。継続的な取引がある等、保有に見合う便益が得られ当社の企業価値向上に繋がるものと判断しております。なお、取引先持株会を通じて定期買付により465株増加しましたが、当事業年度で退会、保有株式を一部売却(22株)しております。","reciprocal":"無","pct_outstanding":0.003787529862153034,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.009520484910031417,"pct_of_holder_assets":0.005832679857164151,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":94533000000,"holder_total_assets_yen":154303000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社バイタルケーエスケー・ホールディングス","holder_name_en":"VITAL KSK HOLDINGS,INC.","holder_sec_code":"3151","doc_id":"S100YDSN","period_end":"2026-03-31","holder_table":"largest","shares":4100,"book_value_yen":6000000,"prior_shares":4100,"prior_book_value_yen":5000000,"purpose_ja":"①商品の確保や仕入の円滑化のため　②該当なし　③ＡがＢを上回っております　④該当なし","reciprocal":"無","pct_outstanding":0.0025046568443270064,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.005054461826177058,"pct_of_holder_assets":0.0018716777719547802,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":118707000000,"holder_total_assets_yen":320568000000,"implausible":false,"reciprocal_held_both_ways":false}],"reclassified":[],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"reporting","note_no":"1","text_ja":"(注) １　「―」は、当該銘柄を保有していないことを示しております。"},{"holder_table":"reporting","note_no":"2","text_ja":"２　当社は、特定投資株式における定量的な保有効果の記載が困難であるため、保有の合理性を検証した方法について記載いたします。当社は、毎年、取締役会において個別の政策保有株式について、保有目的の適否、保有に伴う便益やリスクと資本の効率性を具体的に精査し、保有の適否を検証しており、現状保有する政策保有株式はいずれも保有方針に沿った目的で保有していることを確認しております。"},{"holder_table":"reporting","note_no":"3","text_ja":"３　㈱あいちフィナンシャルグループは当社株式を所有しておりませんが、同社子会社である㈱あいち銀行は当社株式を保有しております。"},{"holder_table":"reporting","note_no":"4","text_ja":"４　第一生命ホールディングス㈱は当社株式を保有しておりませんが、同社子会社である第一生命保険㈱は当社株式を保有しております。また、2026年４月１日付で、株式会社第一ライフグループに社名変更しております。"},{"holder_table":"reporting","note_no":"5","text_ja":"５　㈱みずほフィナンシャルグループは当社株式を保有しておりませんが、同社子会社である㈱みずほ銀行およびみずほ証券㈱は当社株式を保有しております。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"reporting","share_class":"listed","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":2,"sale_proceeds_yen":618000000,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":1,"sale_proceeds_yen":9000000,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":11015000000,"listed_yen":10851000000,"unlisted_yen":164000000,"listed_issues":12,"unlisted_issues":10,"equity_yen":334772000000,"equity_basis":"jgaap_consolidated","total_assets_yen":1213290000000,"assets_basis":"jgaap_consolidated","pct_of_equity":3.2902990692172582,"pct_of_assets":0.9078620939758838,"equity_basis_label":"Consolidated net assets (Japanese GAAP)","assets_basis_label":"Consolidated net assets (Japanese GAAP)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"listed","book_value_yen":10851000000,"issue_count":12,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","book_value_yen":164000000,"issue_count":10,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"unlisted"}],"scale_history":[{"year":"2020","period_end":"2020-03-31","policy_total_yen":23977000000,"equity_yen":161237000000,"equity_basis":"jgaap_consolidated","pct_of_equity":14.870656238952598,"pct_of_assets":2.8823186454532888},{"year":"2021","period_end":"2021-03-31","policy_total_yen":29468000000,"equity_yen":174053000000,"equity_basis":"jgaap_consolidated","pct_of_equity":16.930475200082732,"pct_of_assets":3.448986184392249},{"year":"2022","period_end":"2022-03-31","policy_total_yen":31858000000,"equity_yen":199867000000,"equity_basis":"jgaap_consolidated","pct_of_equity":15.939599833889536,"pct_of_assets":3.4244094242739873},{"year":"2023","period_end":"2023-03-31","policy_total_yen":25098000000,"equity_yen":242173000000,"equity_basis":"jgaap_consolidated","pct_of_equity":10.363665643981781,"pct_of_assets":2.442867863410418},{"year":"2024","period_end":"2024-03-31","policy_total_yen":21639000000,"equity_yen":269788000000,"equity_basis":"jgaap_consolidated","pct_of_equity":8.020742212403814,"pct_of_assets":1.9497738824549184},{"year":"2025","period_end":"2025-03-31","policy_total_yen":7844000000,"equity_yen":311621000000,"equity_basis":"jgaap_consolidated","pct_of_equity":2.517160268402964,"pct_of_assets":0.670104325778001},{"year":"2026","period_end":"2026-03-31","policy_total_yen":11015000000,"equity_yen":334772000000,"equity_basis":"jgaap_consolidated","pct_of_equity":3.2902990692172582,"pct_of_assets":0.9078620939758838}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2020","period_end":"2020-03-31","named_holdings":27,"book_value_yen":23611000000},{"year":"2021","period_end":"2021-03-31","named_holdings":23,"book_value_yen":29023000000},{"year":"2022","period_end":"2022-03-31","named_holdings":22,"book_value_yen":29951000000},{"year":"2023","period_end":"2023-03-31","named_holdings":21,"book_value_yen":23159000000},{"year":"2024","period_end":"2024-03-31","named_holdings":15,"book_value_yen":21137000000},{"year":"2025","period_end":"2025-03-31","named_holdings":15,"book_value_yen":7448000000},{"year":"2026","period_end":"2026-03-31","named_holdings":14,"book_value_yen":10846000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}